Consolidated Statements of Cash Flows (Unaudited) - USD ($)		3 Months Ended
	Mar. 31, 2021	Mar. 31, 2022
Operating activities
Net income		$ 7,803,952
Adjustments to reconcile net income to net cash provided by operating activities:
Accretion of deferred loan origination fees and other discounts		(894,087)
Payment-in-kind interest		(970,569)
Provision for current expected credit losses		48,296
Amortization of deferred debt issuance costs		72,268
Stock-based compensation		120,940
Changes in operating assets and liabilities:
Interest receivable		(175,960)
Other receivables		(10,053)
Interest reserve		(3,084,470)
Management and incentive fees payable		(233,618)
Accounts payable and accrued expenses		358,933
Net cash provided by operating activities		3,035,632
Cash flows from investing activities
Issuance of and fundings of loans		(82,794,575)
Principal repayment of loans		5,619,201
Net cash used in investing activities		(77,175,374)
Cash flows from financing activities
Proceeds from sale of common stock	100,000	4,505,664
Dividends paid		(4,512,329)
Payment of deferred offering costs		(23,941)
Net cash (used in) provided by financing activities	100,000	(30,606)
Change in cash	100,000	(74,170,348)
Cash, beginning of period		80,248,526
Cash, end of period	100,000	6,078,178
Supplemental disclosure of non-cash financing and investing activity
Interest reserve withheld from funding of loan		3,919,974
OID withheld from funding of loans		1,128,415
Dividends declared and not yet paid		$ 7,100,066